Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02869308

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02869308
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02869308. Allocation not applicable; no masking; primary purpose diagnostic. Start 2014-01 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy
Acronym
FEVED
Condition
Angioscintigraphy
Condition
Tomoscintigraphy
Intervention (Drug)
stannous pyrophosphate
Intervention (Drug)
Technetium-99m
Intervention (Device)
E-CAM Camera
Intervention (Device)
CZT Semiconductor Camera (D-SPECT)
Lead sponsor
Central Hospital, Nancy, France (class: other)

Record details

Record id
cardio:ct-nct02869308
Content hash
adf45cf2abff62683816699790223659dfadae482c964eedca670bf24f4155bb